Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Plus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year